Search

everythinglearnresearchcommunity

for

Search:↓

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.